This reference uses VA rating codes. For a code from a medical record, check ICD-10-CM and the service date. A clinical code alone does not establish a VA rating or a matching VA diagnostic code.
Malignant neoplasms of the genitourinary system
Genitourinary · 38 CFR § 4.115b
Diagnostic Code 7528 is the VASRD entry for Malignant neoplasms of the genitourinary system. VA applies the controlling criteria, shared formulas, and special instructions shown in 38 CFR Part 4. VMC presents this material for education and reference; it does not determine a Veteran's diagnosis, service connection, or evaluation.
Recorded index labels
These labels are already stored for this diagnostic code. They are not a new condition, rating, or medical relationship.
Appendix B
- Malignant neoplasms.
Appendix C
- Genitourinary
Print the source-verified reference on this page, or choose Save as PDF in your browser’s print dialog.
Source-verified VASRD criteria
How VA rates this diagnostic code
These percentages summarize the regulatory criteria already mapped to this diagnostic code. They do not predict a Veteran's individual evaluation or establish service connection.
Malignant neoplasms of the genitourinary system
Source-verified VASRD criteria
How VA rates this — Renal dysfunction
These percentages summarize the regulatory criteria already mapped to this diagnostic code. They do not predict a Veteran's individual evaluation or establish service connection.
Chronic kidney disease with glomerular filtration rate (GFR) less than 15 mL/min/1.73 m 2 for at least 3 consecutive months during the past 12 months; or requiring regular routine dialysis; or eligible kidney transplant recipient
Chronic kidney disease with GFR from 15 to 29 mL/min/1.73 m 2 for at least 3 consecutive months during the past 12 months
Chronic kidney disease with GFR from 30 to 44 mL/min/1.73 m 2 for at least 3 consecutive months during the past 12 months
Chronic kidney disease with GFR from 45 to 59 mL/min/1.73 m 2 for at least 3 consecutive months during the past 12 months
GFR from 60 to 89 mL/min/1.73 m 2 and either recurrent red blood cell (RBC) casts, white blood cell (WBC) casts, or granular casts for at least 3 consecutive months during the past 12 months; or GFR from 60 to 89 mL/min/1.73 m 2 and structural kidney abnormalities (cystic, obstructive, or glomerular) for at least 3 consecutive months during the past 12 months; or GFR from 60 to 89 mL/min/1.73 m 2 and albumin/creatinine ratio (ACR) ≥30 mg/g for at least 3 consecutive months during the past 12 months
Source-verified VASRD criteria
How VA rates this — Continual Urine Leakage / Urinary Diversion / Incontinence
These percentages summarize the regulatory criteria already mapped to this diagnostic code. They do not predict a Veteran's individual evaluation or establish service connection.
Requiring the use of an appliance or the wearing of absorbent materials which must be changed more than 4 times per day
Requiring the wearing of absorbent materials which must be changed 2 to 4 times per day
Requiring the wearing of absorbent materials which must be changed less than 2 times per day
Source-verified VASRD criteria
How VA rates this — Urinary frequency
These percentages summarize the regulatory criteria already mapped to this diagnostic code. They do not predict a Veteran's individual evaluation or establish service connection.
Daytime voiding interval less than one hour, or; awakening to void five or more times per night
Daytime voiding interval between one and two hours, or; awakening to void three to four times per night
Daytime voiding interval between two and three hours, or; awakening to void two times per night
Source-verified VASRD criteria
How VA rates this — Obstructed voiding
These percentages summarize the regulatory criteria already mapped to this diagnostic code. They do not predict a Veteran's individual evaluation or establish service connection.
Urinary retention requiring intermittent or continuous catheterization
Marked obstructive symptomatology (hesitancy, slow or weak stream, decreased force of stream) with any one or combination of the following: 1. Post void residuals greater than 150 cc. 2. Uroflowmetry; markedly diminished peak flow rate (less than 10 cc/sec). 3. Recurrent urinary tract infections secondary to obstruction. 4. Stricture disease requiring periodic dilatation every 2 to 3 months
Obstructive symptomatology with or without stricture disease requiring dilatation 1 to 2 times per year
Special rating instructions
- Note —Following the cessation of surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure, the rating of 100 percent shall continue with a mandatory VA examination at the expiration of six months. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no local reoccurrence or metastasis, rate on residuals as voiding dysfunction or renal dysfunction, whichever is predominant.
- Note —Following the cessation of surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure, the rating of 100 percent shall continue with a mandatory VA examination at the expiration of six months. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no local reoccurrence or metastasis, rate on residuals as voiding dysfunction or renal dysfunction, whichever is predominant.
- Rate particular condition as urine leakage, frequency, or obstructed voiding.
Regulatory notes
- Note —Following the cessation of surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure, the rating of 100 percent shall continue with a mandatory VA examination at the expiration of six months. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no local reoccurrence or metastasis, rate on residuals as voiding dysfunction or renal dysfunction, whichever is predominant.
- Note: GFR, estimated GFR (eGFR), and creatinine-based approximations of GFR will be accepted for evaluation purposes under this section when determined to be appropriate and calculated by a medical professional.
Body system and anatomy metadata
Body system: Genitourinary
Anatomy / region tags: genitourinary system
These tags support discovery and body-map compatibility. They do not establish Veteran-specific laterality or entitlement.
Official VA DBQ references
DBQ catalog: va-dbq-2026.09.16 · Retrieved 2026-09-16. Official VA inventory ↗
- Kidney Conditions ↗ Related resourceCatalog category: Genitourinary
Related by body system only. No reviewed condition-specific form match or requirement has been established.
- Male Reproductive Organ Conditions (Including Prostate Cancer) ↗ Related resourceCatalog category: Genitourinary
Related by body system only. No reviewed condition-specific form match or requirement has been established.
- Urinary Tract Conditions ↗ Related resourceCatalog category: Genitourinary
Related by body system only. No reviewed condition-specific form match or requirement has been established.
VA maintains some examination forms that are not available for public use. VMC does not infer a one-code-to-one-DBQ relationship.
Evidence information
When reviewing the criteria, useful evidence categories can include diagnosis and treatment records, objective testing identified by the schedule, documented frequency/duration/severity when the criteria use those concepts, and functional effects described in medical or lay evidence. The relevant evidence depends on the actual claim and medical facts.
VMC does not diagnose conditions, guarantee a percentage, or advise anyone to exaggerate symptoms.
Legal basis and source identification
38 CFR § 4.115b · Source current through 2026-08-06 · Verified 2026-08-10
Registry content release: vasrd-registry-2026.08.1